Hedge Fund - Adams Street Partners
Corvus Pharmaceuticals Inc. (CRVS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $10,416,459 | 9.22% | 3,275,616 | $4.71 |
| 2 | 2024 - Q4 (2024-12-31) | $17,524,546 | 15.53% | 3,275,616 | $7.47 |
| 3 | 2024 - Q3 (2024-09-30) | $17,295,252 | 9.51% | 3,275,616 | $3.59 |
| 4 | 2024 - Q2 (2024-06-30) | $5,961,621 | 2.45% | 3,275,616 | $1.86 |
| 5 | 2024 - Q1 (2024-03-31) | $5,830,596 | 2.31% | 3,275,616 | $2.09 |
| 6 | 2023 - Q4 (2023-12-31) | $5,765,084 | 1.77% | 3,275,616 | $1.46 |
| 7 | 2023 - Q3 (2023-09-30) | $4,782,399 | 1.67% | 3,275,616 | $2.11 |
| 8 | 2023 - Q2 (2023-06-30) | $7,501,161 | 1.96% | 3,275,616 | $2.08 |
| 9 | 2023 - Q1 (2023-03-31) | $2,980,811 | 0.92% | 3,275,616 | $0.78 |
| 10 | 2022 - Q4 (2022-12-31) | $2,784,274 | 0.92% | 3,275,616 | $0.88 |
| 11 | 2022 - Q3 (2022-09-30) | $2,683,000 | 0.73% | 3,275,616 | $0.95 |
| 12 | 2022 - Q2 (2022-06-30) | $3,243,000 | 0.84% | 3,275,616 | $1.23 |
| 13 | 2022 - Q1 (2022-03-31) | $5,373,000 | 0.99% | 3,275,616 | $1.83 |
| 14 | 2021 - Q4 (2021-12-31) | $7,894,000 | 1.2% | 3,275,616 | $3.88 |
| 15 | 2021 - Q3 (2021-09-30) | $15,854,000 | 2.03% | 3,275,616 | $2.96 |
| 16 | 2021 - Q2 (2021-06-30) | $8,746,000 | 1.81% | 3,275,616 | $2.75 |
| 17 | 2021 - Q1 (2021-03-31) | $10,089,000 | 1.61% | 3,275,616 | $3.61 |
| 18 | 2020 - Q4 (2020-12-31) | $11,661,000 | 2.42% | 3,275,616 | $4.03 |
| 19 | 2020 - Q3 (2020-09-30) | $13,135,000 | 3.46% | 3,275,616 | $4.00 |
| 20 | 2020 - Q2 (2020-06-30) | $8,910,000 | 1.84% | 3,275,616 | $2.95 |
| 21 | 2020 - Q1 (2020-03-31) | $6,912,000 | 1.72% | 3,275,616 | $4.06 |
| 22 | 2019 - Q4 (2019-12-31) | $17,819,000 | 3.63% | 3,275,616 | $3.50 |
| 23 | 2019 - Q3 (2019-09-30) | $9,860,000 | 1.97% | 3,275,616 | $4.20 |
| 24 | 2019 - Q2 (2019-06-30) | $12,251,000 | 2.27% | 3,275,616 | $3.92 |
| 25 | 2019 - Q1 (2019-03-31) | $13,168,000 | 2.54% | 3,275,616 | $4.22 |
| 26 | 2018 - Q4 (2018-12-31) | $12,022,000 | 2.52% | 3,275,616 | $6.82 |
| 27 | 2018 - Q3 (2018-09-30) | $28,105,000 | 4.42% | 3,275,616 | $10.00 |
| 28 | 2018 - Q2 (2018-06-30) | $35,966,000 | 5.51% | 3,275,616 | $11.16 |
| 29 | 2018 - Q1 (2018-03-31) | $33,991,000 | 6.48% | 3,275,616 | $9.46 |
| 30 | 2017 - Q4 (2017-12-31) | $27,841,000 | 6.6% | 2,687,381 | $12.80 |
| 31 | 2017 - Q3 (2017-09-30) | $42,837,000 | 10.94% | 2,687,381 | $13.83 |
| 32 | 2017 - Q2 (2017-06-30) | $32,517,000 | 7.62% | 2,687,381 | $10.68 |
| 33 | 2017 - Q1 (2017-03-31) | $55,817,000 | 13.72% | 2,687,381 | $15.66 |
| 34 | 2016 - Q4 (2016-12-31) | $38,430,000 | 10.57% | 2,687,381 | $15.21 |
| 35 | 2016 - Q3 (2016-09-30) | $44,207,000 | 8.32% | 2,687,381 | $14.41 |
| 36 | 2016 - Q2 (2016-06-30) | $28,742,000 | 4.7% | 2,687,381 | $13.51 |
| 37 | 2016 - Q1 (2016-03-31) | $29,225,000 | 5.33% | 2,687,381 | $14.35 |
The displayed share prices are average quarterly stock market prices.